Literature DB >> 17510598

The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury.

Tim Lahm1, Paul R Crisostomo, Troy A Markel, Meijing Wang, Keith D Lillemoe, Daniel R Meldrum.   

Abstract

The pulmonary vascular endothelial cell plays a crucial role in the regulation of the pulmonary vascular tone and in the maintenance of the barrier function and integrity of the alveolar-capillary membrane. It also plays a major role in coagulation, fibrinolysis, and angiogenesis and participates in inflammatory reactions. Vascular endothelial growth factor (VEGF) is a central growth and survival factor for the endothelial cell. Particularly high levels of VEGF are expressed in the lungs, reflecting the critical role of VEGF for lung development and structural integrity of the adult lung. Vascular endothelial growth factor exerts a variety of physiological and pathophysiological actions in the lung. Recent evidence suggests its involvement in the pathogenesis of lung diseases such as bronchopulmonary dysplasia, acute lung injury, emphysema, and pulmonary hypertension. To summarize the critical effects of VEGF on the pulmonary endothelial cell in the pathogenesis of these diseases, the purposes of this review are to (1) discuss the biological activities and intracellular signaling pathways of VEGF in the lung; (2) summarize the regulatory mechanisms involved in VEGF expression; (3)address the effects of VEGF on endothelial cells in hyperoxia-induced and other forms of lung injury; (4) highlight the endothelial effects of VEGF in the pathogenesis of emphysema; and (5) explore the role of VEGF in the pathogenesis of pulmonary arterial hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510598     DOI: 10.1097/shk.0b013e31804d1998

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  22 in total

1.  Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix.

Authors:  Sarah E Gilpin; Xi Ren; Tatsuya Okamoto; Jacques P Guyette; Hongmei Mou; Jayaraj Rajagopal; Douglas J Mathisen; Joseph P Vacanti; Harald C Ott
Journal:  Ann Thorac Surg       Date:  2014-08-19       Impact factor: 4.330

Review 2.  Erythropoetin as a novel agent with pleiotropic effects against acute lung injury.

Authors:  Sotirios Kakavas; Theano Demestiha; Panagiotis Vasileiou; Theodoros Xanthos
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

3.  Effects of trauma, hemorrhagic shock, and chronic stress on lung vascular endothelial growth factor.

Authors:  Tyler J Loftus; Andrew J Thomson; Kolenkode B Kannan; Ines G Alamo; Harry N Ramos; Elizabeth E Whitley; Philip A Efron; Alicia M Mohr
Journal:  J Surg Res       Date:  2016-11-02       Impact factor: 2.192

4.  Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis.

Authors:  Shin-Hwa Lee; An-Soo Jang; Young-Eun Kim; Ji-Yeon Cha; Tae-Hoon Kim; Seok Jung; Seong-Kyu Park; You-Kyoung Lee; Jong-Ho Won; Yong-Hoon Kim; Choon-Sik Park
Journal:  Respir Res       Date:  2010-02-08

5.  Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants.

Authors:  Hideshi Fujinaga; Christopher D Baker; Sharon L Ryan; Neil E Markham; Gregory J Seedorf; Vivek Balasubramaniam; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-04       Impact factor: 5.464

6.  Effects of Vascular Endothelial Growth Factor in Recovery Phase of Acute Lung Injury in Mice.

Authors:  Junfeng Song; Hui Lu; Xuyang Zheng; Xianmei Huang
Journal:  Lung       Date:  2015-09-28       Impact factor: 2.584

7.  Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells.

Authors:  Luke H Hoeppner; Ying Wang; Anil Sharma; Naureen Javeed; Virginia P Van Keulen; Enfeng Wang; Ping Yang; Anja C Roden; Tobias Peikert; Julian R Molina; Debabrata Mukhopadhyay
Journal:  Mol Oncol       Date:  2014-08-30       Impact factor: 6.603

8.  Variations in the vascular endothelial growth factor pathway predict pulmonary complications.

Authors:  Jae Y Kim; Michelle A T Hildebrandt; Xia Pu; Yuanqing Ye; Arlene M Correa; Ara A Vaporciyan; Xifeng Wu; Jack A Roth
Journal:  Ann Thorac Surg       Date:  2012-07-12       Impact factor: 4.330

9.  The PLGA nanoparticles for sustainable release of CGRP to ameliorate the inflammatory and vascular disorders in the lung of CGRP-deficient rats.

Authors:  Fang Wang; Yu Deng; Jieting Wang; Luying Yu; Fadian Ding; Wei Lian; Qicai Liu; Xinhua Lin
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

10.  Dexamethasone attenuates VEGF expression and inflammation but not barrier dysfunction in a murine model of ventilator-induced lung injury.

Authors:  Maria A Hegeman; Marije P Hennus; Pieter M Cobelens; Annemieke Kavelaars; Nicolaas J G Jansen; Marcus J Schultz; Adrianus J van Vught; Cobi J Heijnen
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.